Related references
Note: Only part of the references are listed.Ascites-derived ALDH+CD44+tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer
Jiang Yu-Xin et al.
BRITISH JOURNAL OF CANCER (2020)
Oncogenic miR-20b-5p contributes to malignant behaviors of breast cancer stem cells by bidirectionally regulating CCND1 and E2F1
Liqin Xia et al.
BMC CANCER (2020)
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Stephanie Lheureux et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic et al.
NATURE (2018)
Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis
Hai-Yan Bai et al.
STEM CELLS (2018)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis
Guanming Lu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells
Ting-Ting Cao et al.
CARCINOGENESIS (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth
M. Riverso et al.
ONCOGENE (2017)
Overview of Cancer Stem Cells and Stemness for Community Oncologists
Justin D. Lathia et al.
TARGETED ONCOLOGY (2017)
Prediction of therapy response in ovarian cancer: Where are we now?
Khalid El Bairi et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2017)
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Dany Nassar et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism
Chia-Lin Chen et al.
CELL METABOLISM (2016)
RB1: a prototype tumor suppressor and an enigma
Nicholas J. Dyson
GENES & DEVELOPMENT (2016)
Cancer stem cells: a new approach to tumor development
Natalia Cristina Ciufa Kobayashi et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2015)
Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma
Hong Yang et al.
ONCOTARGET (2015)
Transcriptional control of stem cell fate by E2Fs and pocket proteins
Lisa M. Julian et al.
FRONTIERS IN GENETICS (2015)
Emerging role of nanog in tumorigenesis and cancer stem cells
Luis E. I. V. Santaliz-Ruiz et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention
Brendan Ffrench et al.
MOLECULAR CANCER (2014)
Molecular mechanisms underlying RB protein function
Frederick A. Dick et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
An alternative way for epithelial-to-mesenchymal transition in colorectal cancer via EIF5A2?
Frank T. Kolligs
GUT (2012)
Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition
Wei Zhu et al.
GUT (2012)
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Jaime Prat
VIRCHOWS ARCHIV (2012)
Upregulation of E2F1 in cerebellar neuroprogenitor cells and cell cycle arrest during postnatal brain development
Daniela E. Suzuki et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2011)
Overexpression of Eukaryotic Initiation Factor 5A2 Enhances Cell Motility and Promotes Tumor Metastasis in Hepatocellular Carcinoma
Dong-Jiang Tang et al.
HEPATOLOGY (2010)
Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma
Guo-Fen Yang et al.
GYNECOLOGIC ONCOLOGY (2009)
Multicellular spheroids in ovarian cancer metastases: Biology and pathology
Kristy Shield et al.
GYNECOLOGIC ONCOLOGY (2009)
Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells
Jochen Utikal et al.
JOURNAL OF CELL SCIENCE (2009)
E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells
Jean-Leon Chong et al.
NATURE (2009)
Cancer and stem cell biology: How tightly intertwined?
Carla F. Kim et al.
CELL STEM CELL (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Oncogenic role of eIF-5A2 in the development of ovarian cancer
XY Guan et al.
CANCER RESEARCH (2004)
The E2F1-3 transcription factors are essential for cellular proliferation
LZ Wu et al.
NATURE (2001)
Share Paper
